Gold Nanocluster-Based Capture-Detection Platform for Clinical Diagnosis of Early Lung Cancer
- 30 September 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 7 (19) , 23176-23187
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Henan Province (232300421172)
- Henan Institute of Medical and Pharmacological Sciences (2023BP0204, 2024BP0201)
This publication has 37 references indexed in Scilit:
- Luminescent quantum dots: Synthesis, optical properties, bioimaging and toxicityAdvanced Drug Delivery Reviews, 2023
- Plasma autoantibodies IgG and IgM to PD1/PDL1 as potential biomarkers and risk factors of lung cancerJournal of Cancer Research and Clinical Oncology, 2022
- Screening and identification of B cell epitope of the nucleocapsid protein in SARS-CoV-2 using the monoclonal antibodiesApplied Microbiology and Biotechnology, 2022
- Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapyCancer Immunology, Immunotherapy, 2021
- Gold nanoclusters for theranostic applicationsCoordination Chemistry Reviews, 2021
- Ultrasensitive detection of anti-p53 autoantibodies based on nanomagnetic capture and separation with fluorescent sensing nanobioprobe for signal amplificationBiosensors and Bioelectronics, 2020
- The clinical features, underlying immunology, and treatment of autoantibody‐mediated movement disordersMovement Disorders, 2018
- Glucose decorated gold nanoclusters: A membrane potential independent fluorescence probe for rapid identification of cancer cells expressing Glut receptorsColloids and Surfaces B: Biointerfaces, 2017
- Autoantibody Production in Cancer—The Humoral Immune Response toward Autologous Antigens in Cancer PatientsAutoimmunity Reviews, 2016
- Autoantigen Microarray for High-Throughput Autoantibody Profiling in Systemic Lupus ErythematosusGenomics, Proteomics & Bioinformatics, 2015